WuXi Biologics MFG8 Secures FDA PLI for Autoimmune Therapy
HEBEI, China | July 9, 2026 WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has...
GMP
Advertisement
Nucleus Biologics Launches CRAIC Formulation Finder
SAN DIEGO, Calif., July 7, 2026 Nucleus Biologics has launched CRAIC™ Formulation Finder, a new large language model (LLM)-powered...
RoosterBio and Applied StemCell Partner to Scale iPSC Manufacturing
MILPITAS, Calif. & FREDERICK, Md., July 8, 2026 RoosterBio and Applied StemCell (ASC) have announced a strategic partnership to...
Vector Secures Exclusive cGMP Peptide Manufacturing Deal
MEQUON, Wis., July 7, 2026 Vector Science & Therapeutics Corp. has entered into a landmark exclusive licensing and cGMP...
Olympus Gains FDA Clearance for POWERSEAL Open Device
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEAL™ Open...
Advertisements
Dogwood Secures FDA IND Nod for SP16 Pain Therapy
Alpharetta, Georgia, U.S. | April 15, 2026 Dogwood Therapeutics has announced a major regulatory milestone with the U.S. Food...
ARS Pharma Wins Canada Nod for Needle-Free Epinephrine
San Diego, U.S. | April 15, 2026 ARS Pharmaceuticals has achieved a major regulatory milestone with Health Canada approval...
SynOx Phase 3 Study Shows TGCT Treatment Benefit
DUBLIN, IRELAND, April 13, 2026 SynOx Therapeutics has announced positive topline results from its pivotal Phase 3 TANGENT study,...
Novo Nordisk Secures EMA Approval for Wegovy Delivery Flexibility
Bagsværd, Denmark | April 9, 2026 Novo Nordisk has announced that the European Medicines Agency (EMA) has approved an...
BioOra and Octane Expand CAR-T Manufacturing Globally
WELLINGTON, New Zealand & KINGSTON, Canada, April 7, 2026 BioOra Limited and Octane Biotech Inc. announced a strategic Letter...
Advertisement
